196 SANTE2020C3047 Notification Letter Call for tenders for the development production priority purchasing options Ares 2020 5389787 redacted s.pdf
1 PDF-Seiten
Quelle öffnen →Start / Quellenregister
Dokumentation
Quellenregister
1852 Belegkennungen mit Originaladressen und Fundstellen. Historische Fassungen werden nach ihrem eigenen Datum geführt.
Die Originale und ihre Belegkennungen.
197 1 Notification letter SANTE2020C3047 Development production priority purchasing options and supply of COVID 19 redacted s.pdf
1 PDF-Seiten
Quelle öffnen →197 Notification letter SANTE2020C3047 Development production priority purchasing options and supply of COVID 19 Ares 2021 340726 redacted s.pdf
1 PDF-Seiten
Quelle öffnen →198 Follow up questionnaire sent to Johnson Johnson Janssen 2 Redacted s ok.pdf
1 PDF-Seiten
Quelle öffnen →198 Follow up questionnaire sent to Johnson Johnson Janssen.pdf
5 PDF-Seiten
Quelle öffnen →199 email skype meeting with Johnson Johnson Janssen vaccine 06052020 2 Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →20 1 pro rata adjusted EUROSTAT Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →20 1 pro rata adjusted EUROSTAT Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →20 SB Minutes 17 August 2020 Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →20 SB Minutes 17 August 2020 Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →200 email Report from the TC with J J on COVID 19 Vaccine 2 Redacted s ok.pdf
3 PDF-Seiten
Quelle öffnen →201 Summary J J TC on COVID 19 Vaccine Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →202 RE Summary J J TC on COVID 19 Vaccine rep 2 Redacted s.pdf
6 PDF-Seiten
Quelle öffnen →203 BTO 11 March Mtg J J and SANTE Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →204 email Study Johnson and Johnson vaccine successfully prevents COVID 19 infections in monkeys 2 Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →206 JJ Joins Industry Partners to Launch the 1 Billion AMR Action Fund 2 Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →207 and 208 Re Johnson Johnson announces a Lead Vaccine Candidate for COVID 19 Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →209 RE J J Announces a Lead Vaccine Candidate for COVID 19 Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →21 Email SB Meeting 19 August 2020 Ares 2020 6522258 Redacted.pdf
2 PDF-Seiten
Quelle öffnen →210 email Johnson Johnson COVID 19 vaccine development update launch of Phase 3 clinical trials 2 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →211 email Johnson Johnson COVID 19 treatment development update 2 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →212 APA with Moderna 4 12 2020.pdf
62 PDF-Seiten
Quelle öffnen →213 1 Draft APA negotiated between Moderna and the Evaluation Committee technical on 29 06 2020 Redacted s.pdf
8 PDF-Seiten
Quelle öffnen →214 Draft APA negotiated between Moderna and the Evaluation Committee on 04 11 2020 4 pm Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →215 Draft APA negotiated between Moderna and the Evaluation Committee technical 12 11 2020 Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →216 4 after consultation Draft APA negotiated between Moderna and the Evaluation Committe Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →217 5 Draft APA negotiated between Moderna and the Evaluation Committe Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →218 1 after consultation6 Draft APA negotiated between Moderna and the Evaluation Committe Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →219 Email 7 Draft APA negotiated between Moderna and the Evaluation Committe Redacted s.pdf
5 PDF-Seiten
Quelle öffnen →22 SB Minutes 19 August 2020 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →220 Draft APA negotiated between Moderna and the Evaluation Committee model annex on 19 11 2020 Email Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →221 after consultation Email 9 Draft APA negotiated between Moderna and the Evaluation Committe Redacted s.pdf
5 PDF-Seiten
Quelle öffnen →222 after consultation Email 10 Draft APA negotiated between Moderna and the Evaluation Committ Redacted s.pdf
6 PDF-Seiten
Quelle öffnen →223 after consultation Email 11 Draft APA negotiated between Moderna and the Evaluation Committ Redacted s.pdf
5 PDF-Seiten
Quelle öffnen →224 after consultation Email 12 Draft APA negotiated between Moderna and the Evaluation Committ Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →225 after consultation Email 13 Draft APA negotiated between Moderna and the Evaluation Committ Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →